FDA Seeks Public Comment on Proposed Information Collection for Paperwork Reduction Act Review

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, which will be submitted to the Office of Management and Budget (OMB) for review.